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Regrowth of injured axons across rather small spinal cord lesion gaps and subsequent functional recovery has 
been obtained after many interventions. Long-distance regeneration of injured axons across clinically relevant 
large spinal lesion gaps is relatively unexplored. Here, we aimed at stimulating long-distance regrowth of the 
injured corticospinal (CS) tract. During development, an oriented framework of immature astrocytes is important 
for correct CS axon outgrowth. Furthermore, a continuous growth promoting substrate may be needed to 
maintain a CS axon regrowth response across relatively large spinal lesion gaps. Hence, we acutely transplanted 
poly(D,L)-lactide matrices, which after seeded with immature astrocytes render aligned astrocyte-biomatrix 
complexes (R. Deumens, et al. Alignment of glial cells stimulates directional neurite growth of CNS neurons in 
vitro. Neuroscience 125 (3) (2004) 591-604), into 2-mm long dorsal hemisection lesion gaps. In order to create a 
growth promoting continuum, astrocyte suspensions were also injected rostral and caudal to the lesion gap. 
During 2 months, locomotion was continuously monitored. Histological analysis showed that astrocytes injected 
into host spinal tissue survived, but did not migrate. None of the astrocytes on the biomatrices survived within 
the lesion gap. BDA-labeled CS axons did not penetrate the graft. However, directly rostral to the lesion gap, 
120.9 ± 38.5% of the BDA-labeled CS axons were present in contrast to 12.8 ± 3.9% in untreated control 
animals. The observed anatomical changes were not accompanied by locomotor improvements as analyzed with 
the BBB and CatWalk. We conclude that although multifactorial strategies may be needed to stimulate long-
distance CS axon regrowth, future studies should focus on enhancing the viability of cell/biomatrix complexes 
within large spinal lesion gaps. 
Keywords: Rat; Spinal cord injury; Polylactides; Alignment; Corticospinal; Locomotion 
 
Functional recovery after injury to the central nervous system (CNS) is only very limited. The main cause is the 
absence of spontaneous axon regeneration or regrowth due to an unpermissive environment of the injured CNS. 
Axon regrowth and partial functional recovery after spinal cord injury (SCI) can be stimulated by manipulating 
the injured spinal cord environment. The longest descending axon tract in the spinal cord, the corticospinal (CS) 
tract, has been elicited to regrow after injury upon transplantation of growth promoting cells. Various cellular 
transplants have been used [5], including among others genetically modified cells [8] and olfactory ensheathing 
cells [13,14,18]. However, the SCI models that were used involve single-cut lesions and electrolytic lesions, with 
which relatively small spinal lesion gaps are associated. The lesion gaps in the injured human spinal cord can be 
relatively long. Long-distance regeneration of injured CS axons across relatively large spinal lesion gaps (i.e. 
several millimeters in a rostrocaudal plane) has, thus far, been unsuccessful after transplantation of growth 
promoting cells, such as olfactory ensheathing cells [3] or immature astrocytes [11]. Although injured CS axons 
did not display long-distance regeneration, they were found to regrow into or underneath the cellular grafts that 
were transplanted into the relatively large lesion gaps. The lack of long-distance CS axon regeneration may have 
been influenced by two issues. First, the transplanted glia may have lacked a clear orientation. Developmental 
studies have shown that an oriented astroglial framework is crucial for the correct long-distance outgrowth of the 
CS tract [10]. Also, aligned complexes of astrocytes on biologically degradable matrices have been shown to 
Published in:  Neuroscience Letters (2006), vol. 400, iss. 3, pp. 208-212 
Status : Postprint (Author’s version) 
stimulate directional regrowth of CNS neurons, including CS neurons [4]. Second, no continuum of transplanted 
glia was formed in the injured spinal cord [11], which may have restricted the regrowing CS axons to the area of 
the transplanted glia. 
In the present study we developed a multifactorial strategy that combines orientation of the main cells 
responsible for CS axon growth during development (i.e. immature astrocytes) with a growth supporting (i.e. 
astroglial) continuum in the injured spinal cord. This strategy consisted of (1) acute transplantation of aligned 
astrocyte-biomatrix complexes [4] into a 2-mm long dorsal hemisection lesion gap, and (2) acute injections of 
immature astrocytes rostral and caudal to the lesion gap. Obviously, migration of these injected immature 
astrocytes from the injection sites towards the spinal lesion site is a prerequisite for the creation of an astrocyte 
continuum in the injured spinal cord. 
Astrocytes were obtained from neonatal (post natal day 1) Lewis rats. The method of astrocyte culturing has 
been described elsewhere [4,6]. Fourteen days old cultures containing >95% GFAP positive astrocytes were 
plated onto the surface area of PLA/PLA-b-PEO matrices [16] at a density of about 40,000 cells/cm2 and grown 
on these substrates for 4 days. This protocol rendered aligned astrocyte-biomatrix complexes [4] and these 
complexes were used for transplantation into the spinal lesion site. Identical astrocyte cultures, obtained from the 
same source (Lewis rat pups) were maintained in Petridishes till the day of transplantation and used for the cell 
injections into the rostral and caudal spinal cord stumps. One day before transplantation, both the astrocyte-
biomatrix complexes and the astrocyte cultures were prelabeled with Hoechst. This was done by a 40-60 min 
incubation at 37 °C in 2 µg/ml Hoechst 33342 (Sigma, Uithoorn, The Netherlands) in culture medium: 
DMEM/NUT mix F12 with glutamax-I (Gibco/Invitrogen, Breda, The Netherlands), supplemented with 10% 
inactivated fetal calf serum (Bodinco, Alkmaar, The Netherlands) and antibiotics (100 U/ml penicillin and 100 
µg/ml streptomycin). Thereafter, the astrocyte-biomatrix complexes and the astrocyte cultures were extensively 
washed with culture medium. 
Twenty-seven male Lewis rats (inbred, animal facilities of Maastricht University), 7 weeks old, 200-250 g in 
body weight, were pretrained for CatWalk behavioral testing as described previously [12]. When the animals 
were able to make three consecutive runs on the CatWalk without hesitation, preoperative CatWalk data were 
obtained. Next, the animals received Temgesic (0.1mg/kg body weight; subcutaneous injections; Schering-
Plough, Utrecht, The Netherlands) one hour before surgery. Anesthetization was performed using a mixture of 
O2/N2O (1:2) and halothane (5% for induction of anesthesia and 1-2% as a maintenance dose). A laminectomy 
was performed at T11/T12 and the dura was incised. Using microscissors the dorsal half of the spinal cord was 
incised at two spinal levels, 2 mm apart. The dorsal part of the spinal cord in between the two cuts was removed 
with an aspiration device. The experimental group (n= 12) received astrocyte-biomatrix complexes into the 
lesion site and two astrocyte suspension injections (100,000 cells/µl; 2 µl per injection site; 1 injection 
site/stump), one at 1 mm rostral and the other at 1 mm caudal to the lesion site, both at a depth of 1.2 mm. Dura 
Film was used to cover the lesion site. Control animals (n = 15) did not receive a transplant into the lesion site, 
but received culture medium injections into the rostral and caudal stumps to control for possible damage induced 
by the injection procedure. The wounds were sutured and the animals returned to their home cages. At 6 weeks 
after injury, BDA labeling of the CS tract was performed in the animals via an identical method as described 
previously [11]. 
At 9 weeks after SCI, i.e. 3 weeks after CS tract tracing, all animals were anesthetized (Nembutal, 30 mg/kg 
body weight; i.p. injection) and transcardially perfused with ice-cold 4% paraformaldehyde in 0.1 M phosphate 
buffer (pH 7.4). The spinal cords were removed and post-fixed in cold 4% buffered paraformaldehyde overnight. 
The cryoprotection protocol consisted of an overnight incubation in 10% sucrose in PBS (0.1 M; pH 7.6; 4°C) 
followed by a 3-day incubation in 25% sucrose in PBS at 4°C. Thereafter, 2.5-cm long spinal cord pieces 
including the lesion site were frozen and stored at -80°C. The spinal cord pieces were serially cut on a cryostat 
(sagittal sections of 25 µm) and the sections were immediately mounted on gelatin chrome-alumn (Sigma, 
Uithoorn, The Netherlands) coated glass slides and stored at -20°C. Alternate sections were processed for 
immunohistochemistry. Sections were washed in the following sequence: 0.3% Triton X-100 in Tris-buffered 
saline (TBS-T), TBS, and TBS-T (10 min each step). Rabbit anti-GFAP (1:1000; DAKO, Glostrup, Denmark) 
and rabbit anti-GAP43/B50 (generous gift from Leo van Halewijn, Utrecht University, The Netherlands) were 
used as primary antibodies, diluted in TBS-T and incubations were overnight at room temperature. After 
washing, the sections were incubated with secondary antibodies for 1.5 h at room temperature. The secondary 
antibodies used were streptavidin-Cy3 (1:2000; for the BDA-labeled CS axons; Jackson ImmunoResearch 
Europe Ltd., Cambridgeshire, UK) and Alexa488-conjugated goat anti-mouse (1:100; Molecular 
Probes/Invitrogen, Breda, The Netherlands). Stained sections were analyzed using an Olympus AX-70 
microscope using epi-fluorescent illumination. The microscope was equipped with a x20 objective and a x10 
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projection lens. Pictures of the stained sections were made at a magnification of x20 using an Olympus F-view 
cooled CCD camera (Paes, Zoeterwoude, The Netherlands). All pictures were analysed with the image analyzing 
system analySIS Vers. 3.0. (Soft Imaging System, Munster, Germany). 
All sections with BDA labeled CS axons were analyzed. For quantitative analysis, 250-µm-wide-boxes were 
placed at four different locations in the spinal cord sections (Fig. 1D). The first box was placed in the dorsal 
grey/white matter at 2.5-3 mm rostral to the injury site and will be designated as "the rostral reference". The 
second box was placed in the dorsal grey/white matter area directly rostral to the injury site. The third box was 
placed in the grey matter underneath the lesion site. Since only few axons were present underneath the lesion 
site, the box was placed in the area where most BDA immunore-activity was found. The fourth box was placed 
in the grey matter caudal to the injury site, again at the position where most BDA immunoreactivity could be 
found. The few BDA immunoreac-tive CS axons were exclusively present within the caudal grey matter within 
10 mm from the caudal edge of the lesion site. All four boxes were analyzed in all the sections containing BDA 
labeled CS axons. The percentage of each box occupied by BDA immunoreactive axons ("BDA 
immunoreactivity occupation") was measured and the box values in all the sections were summed. Since the 
efficiency of CS tracing with BDA was highly variable among animals, the BDA immunoreactivity at the rostral 
reference was taken as the 100% reference value of BDA labeled axons of each animal. The BDA 
immunoreactivity values of boxes 2, 3, and 4 were expressed relative to that of the rostral reference. A similar 
quantification method has been described previously by others [7]. 
Behavioral evaluation of the animals was performed throughout the 9 weeks post-operative period, using the 
BBB locomotor rating scale [1] and the CatWalk gait analysis [9], the latter according to previous 
recommendations [12]. 
In saggital spinal cord sections of all astrocytes-transplanted animals, many Hoechst-prelabeled cells were 
detected around both the rostral and caudal injection sites. GFAP immunostain-ing confirmed that these Hoechst 
cells were indeed astrocytes (Fig. 1A). However, prelabeled astrocytes were not detected at or near the biomatrix 
complex that was located within the lesion site. BDA-labeled CS axons were clearly visible rostral to the injury 
site in all astrocyte-transplanted animals and in all-but-one control animal. Many retraction bulbs were observed 
at the endings of these BDA-labeled CS axons in both transplanted and control animals (Fig. 1B and C). The 
majority of BDA-labeled CS axons stopped at the rostral lesion border and only very few grew in the sublesional 
grey matter and in the caudal grey matter. No BDA-labeled CS axons were observed to penetrate the lesion/graft 
area. Quantitatively, a significantly enhanced BDA immunoreactivity was detected directly rostral to the injury 
site (box 2 in Fig. 1D) in astrocyte transplanted (n = 7) versus control animals (n = 7) (p < 0.05) (Fig. 1E). None 
of the BDA-labeled CS axons in this study was found to be immunoreactive for GAP43/B-50, a marker molecule 
known to be involved in axon growth [19,21]. 
Behaviorally, the animals (n= 15) showed a significant drop in BBB score directly after injury followed by a 
gradual increase to a plateau-phase (Fig. 1F) as reported earlier [11]. Although there was a clear time effect for 
the BBB score (Time: F12,13 = 170.48, p <0.01), there was no difference between groups (Group: F1,13 = 0.77, 
n.s.). Next to this, many CatWalk parameters were tested. Among these, the stride length of the hind limbs, 
which has been linked to the CS tract [20], was significantly reduced after injury (Time: F1,13 = 20.40, p < 0.01) 
with no difference between groups (Group: F1,13 =0.058, n.s.) (Fig. 1G). 
This study describes a multifactorial transplantation strategy which was unsuccessful in stimulating regrowth of 
injured CS axons across relatively large lesion gaps. This strategy only enhanced the presence of injured CS 
axons detected directly rostral to the lesion gap. This was not paralleled by any functional improvement till 9 
weeks after injury, as assessed with the BBB locomotor rating scale or CatWalk gait analysis. 
Among cell transplantation strategies to stimulate CS axon regrowth across discrete electrolyte or single-cut 
spinal lesion sites, olfactory ensheathing cell (OEC) transplants have been shown to be useful [13,18]. Clinically, 
relatively large spinal lesion gaps of at least several millimeters occur and the use of OEC transplants to 
stimulate CS axon regrowth across such larger lesions has been more limited [3]. Long-distance CS axon 
growth, however, occurs during development and a continuous oriented framework of immature astrocytes is 
thought to be responsible [10]. In a first study, immature astrocytes were embedded in a collagen matrix and 
subsequently transplanted into 2-mm long dorsal hemisection lesion gaps [11]. These transplanted astrocytes 
most likely did not adopt an oriented phenotype and were only present within the spinal lesion gap [11]. From 
previous work we know that the use of oriented ρoly(D,L)-lactide matrices enables the creation of aligned 
astrocyte-biomatrix substrates [4]. Although the present study aimed at creating (1) an aligned astrocyte-
biomatrix substrate within the lesion gap, and (2) a continuum of immature astrocytes within the lesioned spinal 
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cord, both of these aims were not achieved. Hoechst-prelabeled transplanted cells were only detected in a 
clustered fashion within the injection areas rostral and caudal to the lesion gap. No prelabeled cells were detected 
on the poly(D,L)-lactide matrices, which strongly suggests that these transplanted cells did not survive on these 
matrices within the lesion gaps. An alternative explanation for the lack of prelabeled cells on the biomatrices is 
that they migrated away from the biomatrices in the direction of the injection areas. However, since the 
prelabeled cells within these injection areas were strongly clustered and no putative migratory tracts could be 
observed this explanation is rather unlikely. 
 
Fig. 1. Neuropathological and behavioral effects of astrocyte transplantation. Hoechst-prelabeled (blue) 
transplanted astrocytes, immunoreactive for GFAP (red) readily survived within the injection areas rostral (A) 
and caudal to the spinal lesion gap. Note in panel (A) that autofluorescent macrophages can be detected by 
yellowish fluorescence. BDA-labeled corticospinal axons approached the spinal lesion site more closely in 
astrocyte transplanted animals (B) than in control animals (C). Note that panels B and C are taken directly rostral 
to the lesion gap (box 2 in panel D) and in both panels retraction bulbs can be observed at the end of the BDA-
labeled CS axons. (D) Four different boxes were placed in the injured spinal cord. BDA immunoreactivity was 
measured in these boxes; box 1 was taken as a reference box. Quantitative analysis showed a significantly 
reduced die-back of corticospinal axons in astrocyte transplanted animals versus control animals directly rostral 
to the injury site (E). Behavioral analysis using the BBB locomotor scale (F) and the CatWalk gait analysis (G) 
showed that the astrocyte intervention did not stimulate any recovery as compared to control animals. DPO, days 
post operation; w, white matter; g, grey matter; t, transplant; BDA, biodextran amine;  *p<0.05. 
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The survival of transplanted immature astrocytes on the poly(D,L)-lactide matrices may have been negatively 
influenced by the rather 'unprotected' location. When immature astrocytes were embedded within a collagen 
matrix and then transplanted into 2-mm long dorsal hemisection sites, the transplanted astrocytes readily 
survived [11]. However, in the present study the astrocytes were cultured merely on the surface of the ρoly(D,L)-
lactide matrix, which renders these cells directly exposed to the high concentrations of cytotoxic substances 
released by pathological processes, such as hemorrhage and inflammation [17], which may have negatively 
affected the survival of these cells. In addition, it has been shown that injured spinal cord tissue influences the 
well-being of Schwann cells [22], and may also exert detrimental effects on the survival of astrocytes 
transplanted into our dorsal hemisection lesion gaps. Survival of transplanted immature astrocytes may benefit 
not only from culturing these cells within biomatrices, but also from the specific biomaterial used. Degradation 
of polylactides is associated with a lowering of the pH [15], which may also negatively affect the survival of the 
transplanted immature astrocytes. Hence, future studies may focus on the development of aligned astrocyte-
biomatrix complexes, which are more viable after transplantation in spinal lesion gaps. 
Although our strategy was associated with no survival of the transplanted cells within the lesion gap and poor 
migration of the transplanted cells from the injection sites, BDA immunoreactivity directly rostral to the lesion 
gap equaled that at 2.5-3 mm rostral to the lesion gap. In contrast, control animals here showed an over 85%-
reduction in BDA immunoreactivity (p < 0.05). BDA-labeled CS axons were never observed to penetrate the 
biomatrices, which may reflect the rather low intrinsic capacity of injured CS axons to regrow [5]. Other studies 
also showed the inability of injured CS axons to use organic implants, such as human amnion ECM material, 
collagen implants and laminin-coated nitrocellulose filters to cross lesion gaps [2]. Of the rostrally located 
injured BDA-labeled CS axons, none was immunoreactive for GAP43/B50 in neither transplanted nor control 
animals. This suggests that the higher BDA immunoreactivity directly rostral to the lesion gap in transplanted 
animals reflects a die-back response of these axons, rather than a sprouting response. The nature of this die-back 
response may be investigated in future studies focusing on the BDA-labeled CS axons at subsequent time points 
after injury and how these axons are affected by the transplanted immature astrocytes. Electronmicroscopic 
analysis may be used to see whether the enhanced BDA immunoreactivity immediately rostral to the lesion gap 
after astrocyte transplantation involves a swelling of the BDA-labeled CS axons and/or a reduction in the 
number of BDA-labeled CS axons retracting. Interestingly, we never observed a contact between the 
transplanted astrocytes and the BDA-labeled CS axons. Hence, the effects of the rostrally injected astrocytes on 
the injured CS axons are most probably mediated by diffusible factors rather than by contact-mediated 
mechanisms. Functionally, the intact CS tract has been linked with stride length of the hind limbs [2,20]. In our 
study we did not detect any recovery in stride length of the hind limbs in astrocyte transplanted animals versus 
controls. Obviously, an enhanced presence of injured CS axons rostral to a low-thoracic lesion gap is insufficient 
in stimulating recovery in this behavioral parameter. 
In summary, our results demonstrate that CS axon regrowth into, across, and from a relatively large spinal lesion 
gap cannot be stimulated by a multifactorial transplantation strategy using aligned grafts of immature astrocytes 
on poly(D,L)-lactide matrices and astrocyte injections into the host spinal tissue. Future studies may focus on the 
nature of the die-back response in the presence of transplanted astrocytes. If the die-back response reflects a 
reduction in the number of axon retracting from the lesion gap, the transplantation strategy may strongly benefit 
from treatments enhancing survival of transplanted immature astrocytes within the spinal lesion gaps in its effect 
to stimulate long-distance axon regeneration across spinal lesion gaps. 
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